retatrutide-ruo 20mg Retatrutide Research Peptide Retatrutide 20mg Peptides | 99%

(2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

(2024g, February 29)

Most patients see improvement within 14 weeks once they increase water intake, improve oral hygiene, and adjust their diet

It is also prescribed off-label by healthcare providers for chronic weight management in adults who are obese or overweight with at least one weight-related comorbidity

Most guidance lands somewhere around 0.71 gram of protein per pound of goal body weight for people actively losing weight and training, though your prescriber or dietitian should set your number